tirzepatide patient education Tirzepatide Weight Loss Patient Educational
Description
Seen in a longer historical context, the excitementand the discomfortaround menopause, hormones, and weight-loss pharmacotherapy makes sense
Tirzepatide belongs to a class of medications called GLP-1 and GIP receptor agonists, originally developed to treat type 2 diabetes before showing remarkable results for weight management
If you notice low energy, dizziness, or trouble finishing workouts, check in with your prescribing clinician and consider adjusting your plan
No se ha observado incremento en hipoglucemias graves cuando se usa sin insulina basal o sulfonilureas
This may result in pain and irritation
